LARIMAR THERAPEUTICS
7.2000
08-October-24 14:12:44
15 minutes delayed
Stocks
+0.7200
+11.11%
Today's range
6.4500 - 7.4700
ISIN
N/A
Source
NASDAQ
-
Larimar Therapeutics to Participate in the Piper Sandler 33rd Annual Healthcare Conference
22 Nov 2021 07:00:01 By Nasdaq GlobeNewswire
-
Larimar Therapeutics to Participate in the Guggenheim Virtual Neuro/Immunology Conference
15 Nov 2021 07:00:03 By Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
12 Nov 2021 07:00:02 By Nasdaq GlobeNewswire
-
16 Sep 2021 08:00:02 By Nasdaq GlobeNewswire
-
Larimar Therapeutics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
02 Sep 2021 16:01:00 By Nasdaq GlobeNewswire
-
Larimar Therapeutics Announces Upcoming Oral Presentation at the World Orphan Drug Congress
19 Aug 2021 07:00:00 By Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
12 Aug 2021 07:00:01 By Nasdaq GlobeNewswire
-
Larimar Therapeutics to Present at the William Blair Biotech Focus Conference 2021
08 Jul 2021 16:01:00 By Nasdaq GlobeNewswire
-
Larimar Therapeutics to Present at the JMP Securities Life Sciences Conference
11 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
25 May 2021 17:41:45 By Nasdaq GlobeNewswire
-
Larimar Therapeutics Announces $95 Million Private Placement Financing
21 May 2021 09:18:23 By Nasdaq GlobeNewswire
-
20 May 2021 16:31:11 By Nasdaq GlobeNewswire
-
11 May 2021 07:00:01 By Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports First Quarter 2021 Operating and Financial Results
10 May 2021 16:05:01 By Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Fourth Quarter and Full Year 2020 Operating and Financial Results
04 Mar 2021 07:00:01 By Nasdaq GlobeNewswire
-
Larimar Therapeutics to Present at the SVB Leerink 10th Annual Global Healthcare Conference
18 Feb 2021 16:01:00 By Nasdaq GlobeNewswire